Tumoural VEGF‐C also acted paracrinely to induce macrophage recruitment, and resultantly promoted clinical nonsmall cell lung cancer cell metastasis.27 Moreover, a decrease in TAM (CD45+, CD11b+, F4/80+) was observed upon axitinib treatment in both subcutaneous MC38 and LLC1 tumour cells.28 The gene discussed is VEGFC; the disease is neoplasm.